Dr. Daniel Rahul Agarwal, MD

Dr. Agarwal practices at San Luis Obispo Eye Associates, a Medical Group Inc. in Templeton, California.

Dr. Agarwal's NPI, 1811230766, was assigned on March 28, 2013. Dr. Agarwal graduated from Weill Cornell Medicine in 2013. Dr. Agarwal holds California license A168859.

Dr. Agarwal's primary practice is San Luis Obispo Eye Associates, a Medical Group Inc., at 234 Heather Ct, Templeton, CA 93465 in San Luis Obispo County. The practice phone is (805) 781-3937.

Dr. Agarwal's primary practice is San Luis Obispo Eye Associates, a Medical Group Inc. in Templeton, California. Dr. Agarwal is also affiliated with Dignity Health - Marian Regional Medical Center. The medical group on file is Harbor-UCLA Medical Center. Dmand AI also links Dr. Agarwal to 1 more hospital, 4 group practices and clinics and 4 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Agarwal practices, 6 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Agarwal's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Agarwal is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Agarwal's licenses on file in 3 states: California, Connecticut and Ohio.

Dmand AI lists age-related macular degeneration, cataract, cold sores or genital herpes, dry eye, eyelid inflammation, glaucoma, hypertensive retinopathy and inflammation of iris among the conditions Dr. Agarwal treats.

CMS data shows 50,833 Medicare services from Dr. Agarwal across 16 procedure codes in 2024, for 1,045 Medicare patients. Medicare paid $2,071,089 for them.

CMS counts 1,045 Medicare patients who saw Dr. Agarwal in 2026. The largest group is 65 to 74, with 424 patients. 75% of them have high cholesterol, and 73% have high blood pressure. 13% are also on Medicaid. Their average risk score is 1.24, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Agarwal's median patient age at 73, with 54% women.

In 2026, Dr. Agarwal wrote 594 Medicare Part D claims for 165 patients. 63% of them were for generic drugs. CMS names the drug for 505 of them, across 12 drugs with 11 or more claims each, at $16,095 in total drug cost. In 2023, CMS named 477 claims across 10 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 96 out of 100 for Dr. Agarwal for performance year 2026, reported as part of a group. Dr. Agarwal accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Cataract surgery: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 11 papers to Dr. Agarwal, published from 2011 to 2021. 2015 was the busiest year, with 4. Dr. Agarwal has published most often in Clin Ophthalmol. Dr. Agarwal's most frequent co-authors are Rachel Ann Gelman, MD, Claudia Maria Prospero Ponce and William T. K. Stevenson, MD.

CMS Open Payments shows 118 general payments to Dr. Agarwal from 17 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 42% of the total. Regeneron Pharmaceuticals, Inc. paid the most, $4,030.

Dr. Agarwal graduated from Weill Cornell Medicine in 2013.

Dr. Agarwal is in network with 21 carriers, including Aetna, Blue Cross Blue Shield of Michigan and HCSC. HMO plans come from the most carriers, 13. Check the plan with the practice before a visit.